Insider trades
Johannes Jacob Pieter Kastelein, Chief Officer of NewAmsterdam Pharma NAMS, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $10.9M. The latest trade was on 03/09.
Johannes Jacob Pieter Kastelein
Chief Scientific Officer
- Company
- NewAmsterdam Pharma NAMS
- First filing
- 24/01/03
- Trades
- 30 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$10.9M
- Last trade
- 03/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NAMS | Open-market sale10b5-1 plan | 03/05–03/09 | 03/09 | 300,000 sh3 trades | $30.30avg. | $9,090,868.39 | −81.2% |
NAMS | Open-market sale | 02/20 | 02/24 | 45,481 sh2 trades | $35.31avg. | $1,605,997.94 | −45.9% |
| Open-market sale10b5-1 plan | 01/05 | 01/07 | 6,000 sh | $33.25 | $199,500 | −7.5% | |
NAMS | Open-market sale | 25/08/21–25/08/22 | 25/08/25 | 100,000 sh3 trades | $24.72avg. | $2,471,639.78 | −59.1% |
| Open-market sale | 24/03/26 | 24/03/27 | 190,476 sh | $21.50 | $4,095,234 | −100.0% |